January 2019 Print this issue Treatment Can Delay Future Attacks Most of the time, multiple sclerosis, or MS, starts mildly, with unpredictable symptoms that can seem baffling. Without treatment, the disease can worsen to the point that you can’t write, speak, or walk. MS starts when the body’s immune systemThe system that protects your body… Read More »
British scientists have developed a new medicine that may prevent and even stop brain cells degeneration. The medicine was made from Brussel sprouts and carrots, both rich in vitamin A. Researchers from the University of Aberdeen and Durham developed synthetic vitamin A after a two-year project that cost $ 250,000. They recently announced that they… Read More »
Print this page KENILWORTH, N.J.–(BUSINESS WIRE) December 19, 2018 –Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma (MCC), based… Read More »
FILE PHOTO: A man walks past Pfizer’s world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo (Reuters) – Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease.… Read More »